Mirati Therapeutics Competitors and Similar CompaniesClear all
Mirati Therapeutics's competitors and similar companies include Verastem Oncology, Agenus and Anavex.
 Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. |  Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. | |
Founding Date | Founding Date 2013 | Founding Date 2010 | Founding Date 1994 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations San Diego, US HQ Zug, CH | Locations Needham, US HQ Walsrode, DE | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations New York, US HQ Reno, US |
Employees | Employees 15810% decrease | Employees 7328% increase | Employees 38927% decrease | Employees 1623% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 144.9 m | Valuation ($) 96.2 m | Valuation ($) 484.6 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $12.4m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $156.3m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $600k (FY, 2022) | Cost of goods N/A | Cost of goods $3.1m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $11.8m (FY, 2022) | Gross profit N/A | Gross profit $153.2m (FY, 2023) | Gross profit N/A |
Net income | Net income ($740.9m) (FY, 2022) | Net income ($87.4m) (FY, 2023) | Net income ($257.4m) (FY, 2023) | Net income ($43m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 170m | Total funding raised $ 171.1m | Total funding raised $ 12.6m |
For sources of this data, please see the company profile
View Company Profiles
Verastem Oncology
HQ
Needham, US
Employees
73↑ 28% increase
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View companyAgenus
HQ
Lexington, US
Employees
389↓ 27% decrease
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View companyAnavex
HQ
New York, US
Employees
16↑ 23% increase
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View company